Estados financieros detallados de Gain Therapeutics, Inc. (GANX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.72, GANX presenta beneficios negativos (P/E no significativo) y un ROE del -161.58%. La capitalización bursátil es de $73M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $20609 | $41301 | $28881 | $164994 | $140108 | $55180 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $20609 | $41301 | $28881 | $164994 | $140108 | $55180 | 0 | 0 |
| I+D | $826880 | $1.6M | $2.3M | $7.2M | $8.4M | $11.5M | $10.8M | $10.2M |
| Generales y Administrativos | $222047 | $555165 | $1.2M | $6.8M | $9.5M | $10.8M | $9.6M | $8.5M |
| Gastos Operativos | $1.0M | $2.1M | $3.5M | $14.0M | $17.9M | $22.3M | $20.4M | $18.7M |
| Beneficio Operativo | -$1.0M | -$2.1M | -$3.5M | -$13.8M | -$17.8M | -$22.3M | -$20.4M | -$18.7M |
| EBITDA | -$1.0M | -$2.1M | -$3.5M | -$13.9M | -$17.4M | -$22.1M | -$19.8M | -$19.2M |
| Gastos por Intereses | $52477 | $20540 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.1M | -$2.2M | -$3.6M | -$13.9M | -$17.5M | -$22.2M | -$19.9M | -$19.3M |
| Impuestos | $9781 | $7114 | $5386 | $4008 | $92976 | $79275 | $536815 | $861118 |
| Beneficio Neto | -$1.1M | -$2.2M | -$3.6M | -$13.9M | -$17.6M | -$22.3M | -$20.4M | -$20.2M |
| BPA | $-0.19 | $-0.37 | $-0.30 | $-1.37 | $-1.48 | $-1.71 | $-0.89 | $-0.61 |
| BPA Diluido | $-0.19 | $-0.26 | $-0.30 | $-1.37 | $-1.48 | $-1.71 | $-0.89 | $-0.61 |
| Acciones en Circulación (Diluidas) | $5.9M | $8.4M | $11.9M | $10.2M | $11.9M | $13.0M | $22.9M | $33.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$4.8M | -$4.5M | -$5.4M | -$4.7M |
| EBITDA | -$4.7M | -$4.4M | -$5.4M | -$4.5M |
| Beneficio Neto | -$5.3M | -$4.5M | -$5.6M | -$4.7M |
| BPA | $-0.15 | $-0.11 | $-0.13 | $-0.11 |
| BPA Diluido | $-0.15 | $-0.11 | $-0.13 | $-0.11 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $400694 | $303320 | $7.5M | $36.9M | $7.3M | $11.8M | $10.4M | $20.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $12.8M | $5.0M | 0 | 0 |
| Cuentas por Cobrar | 0 | $44915 | $8548 | $195448 | $103877 | $242577 | $765763 | $802693 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $494638 | $398047 | $9.0M | $37.7M | $21.1M | $17.8M | $11.6M | $22.2M |
| Inmovilizado Material | $305787 | $219348 | $552713 | $1.0M | $804312 | $585177 | $323334 | $409006 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $202609 | $213967 | $193375 | $134268 | $102837 |
| Activos Totales | $811634 | $660286 | $9.6M | $39.0M | $24.1M | $18.6M | $12.1M | $22.8M |
| Cuentas por Pagar | $149333 | $154441 | $961516 | $560479 | $1.6M | $1.3M | $946259 | $825027 |
| Deuda a Corto | 0 | $102107 | $22626 | $103826 | $108135 | $118797 | $110177 | $100869 |
| Pasivos Corrientes | $530786 | $879052 | $2.1M | $2.6M | $4.1M | $4.9M | $3.9M | $3.4M |
| Deuda a Largo | $1.0M | 0 | $715656 | $590468 | $495258 | $449053 | $328327 | $300084 |
| Pasivos Totales | $1.8M | $1.1M | $3.4M | $4.2M | $5.2M | $6.0M | $4.8M | $4.3M |
| Reservas | -$1.3M | -$3.5M | -$7.0M | -$20.9M | -$38.5M | -$60.8M | -$81.2M | -$101.4M |
| Patrimonio Neto | -$950908 | -$449856 | $6.2M | $34.8M | $18.9M | $12.6M | $7.3M | $18.6M |
| Deuda Total | $1.3M | $200950 | $1.3M | $1.6M | $1.3M | $1.0M | $653015 | $732067 |
| Deuda Neta | $904670 | -$102370 | -$6.2M | -$35.3M | -$18.9M | -$15.8M | -$9.7M | -$20.1M |
| Capital Circulante | -$36148 | -$481005 | $6.9M | $35.2M | $17.0M | $12.8M | $7.7M | $18.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $8.8M | $20.8M | $16.5M | $13.1M |
| Activos Totales | $11.0M | $22.8M | $18.7M | $15.4M |
| Pasivos Totales | $5.1M | $4.3M | $4.7M | $4.1M |
| Patrimonio Neto | $5.9M | $18.6M | $14.0M | $11.3M |
| Deuda Total | $605278 | $732067 | $672302 | $609874 |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$1.1M | -$2.2M | -$3.6M | -$13.9M | -$17.6M | -$22.3M | -$20.4M | -$20.2M |
| Amortizaciones | $741 | $2571 | $9592 | $15484 | $64168 | $83579 | $84071 | $94046 |
| Compensación en Acciones | 0 | 0 | $81640 | $839371 | $1.5M | $3.3M | $2.4M | $1.8M |
| Cambio en Capital Circulante | $319234 | $312261 | $237504 | -$329784 | $1.5M | $442230 | -$1.1M | -$1.0M |
| Flujo de Caja Operativo | -$744514 | -$1.9M | -$3.2M | -$12.4M | -$14.7M | -$18.9M | -$18.9M | -$18.5M |
| Inversiones (CapEx) | -$7987 | -$13723 | -$20826 | -$94212 | -$118953 | -$15358 | -$22493 | $2 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$752501 | -$1.9M | -$3.3M | -$12.5M | -$14.8M | -$18.9M | -$18.9M | -$18.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$4.9M | -$4.6M | -$4.7M | -$4.7M |
| Inversiones (CapEx) | -$4 | -$3 | -$3 | $5 |
| Flujo de Caja Libre | -$4.9M | -$4.6M | -$4.7M | -$4.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $460005 | $401667 | $403509 | $566050 |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +100.4% | -30.1% | +471.3% | -15.1% | -60.6% | -100.0% | |
| Crecimiento Beneficio Neto (anual) | | -98.4% | -63.1% | -288.3% | -26.6% | -26.6% | +8.3% | +1.2% |
| Crecimiento BPA (anual) | | -94.7% | +18.9% | -356.7% | -8.0% | -15.5% | +48.0% | +31.5% |
| Cambio en Acciones (anual) | | +42.9% | +41.8% | -14.4% | +16.9% | +9.5% | +75.9% | +44.1% |
| Crecimiento FCF (anual) | | -150.1% | -73.3% | -282.1% | -18.9% | -27.5% | -0.1% | +2.3% |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | |
| Margen Operativo | -4989.7% | -5084.9% | -12047.5% | -8379.8% | -12688.1% | -40328.3% | | |
| Margen EBITDA | -4986.1% | -5078.7% | -12014.3% | -8407.0% | -12443.0% | -40059.2% | | |
| Margen Neto | -5364.4% | -5310.9% | -12387.7% | -8418.9% | -12555.1% | -40354.3% | | |
| Margen FCF | -3651.3% | -4557.4% | -11291.4% | -7551.7% | -10571.2% | -34217.5% | | |
| Tasa Impositiva Efectiva | -0.9% | -0.3% | -0.2% | -0.0% | -0.5% | -0.4% | -2.7% | -4.5% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.13 | $-0.22 | $-0.27 | $-1.23 | $-1.25 | $-1.45 | $-0.83 | $-0.56 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $5.9M | $8.4M | $11.9M | $10.2M | $11.9M | $13.0M | $22.9M | $33.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -161.58% |
| Rentabilidad sobre capital invertido | -157.82% |
| Rentabilidad sobre activos | -130.37% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.05 |
| Ratio corriente | 4.36 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 7.04 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -58.95 | -30.27 | -37.33 | -3.96 | -2.11 | -1.91 | -2.43 | -5.28 |
| P/VC | -69.02 | -208.45 | 21.45 | 1.59 | 1.97 | 3.38 | 6.73 | 5.72 |
| P/V | 3184.70 | 2270.50 | 4605.67 | 334.55 | 265.47 | 771.06 | 0.00 | 0.00 |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% |
| Margen Operativo | -4989.7% | -5084.9% | -12047.5% | -8379.8% | -12688.1% | -40328.3% | 0.0% | 0.0% |
| Margen Neto | -5364.4% | -5310.9% | -12387.7% | -8418.9% | -12555.1% | -40354.3% | 0.0% | 0.0% |